Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptima Health Regulatory News (OPT)

Share Price Information for Optima Health (OPT)

Share Price is delayed by 15 minutes
Get Live Data
193.00    0.00 (0.00%)
Bid:
190.00
Ask:
196.00
Spread: 6.00 (3.158%)
Market Cap: £209.39m
OPT Live PriceLast checked at - London Stock Exchange

Intraday Optima Health Share Chart

Director/PDMR Shareholding

28 Apr 2026 07:00

RNS Number : 1102C
Optima Health PLC
28 April 2026
 

28 April 2026

Optima Health plc

("Optima", the "Company", and, together with its subsidiaries, the "Group")

Director / PDMR Dealings

Optima Health (AIM: OPT), the UK's leading provider of technology enabled corporate health and wellbeing solutions, announces that following Admission of the Open Offer shares on 23 April 2026, the Directors / PDMRs, Julie Robertson, Jonathan Thomas, Heidi Giles, Simon Arnold, Adam Councell and Joanne Newey have subscribed for an aggregate of 51,560 Open Offer Shares, representing approximately 0.05% of the Company's enlarged issued share capital.

Details of the Ordinary Shares held by each of the Directors/PDMRs are detailed below:

Director/PDMR

Current shareholding

% of issued share capital

Shareholding immediately following Admission

% of the enlarged issued share capital following Admission

Julia Robertson

21,500 Ordinary Shares

0.02

26,343

0.02

Jonathan Thomas

218,356 Ordinary Shares

0.25

229,856

0.21

Heidi Giles

83,228 Ordinary Shares

0.09

92,000

0.08

Simon Arnold

20,451 Ordinary Shares

0.02

32,100

0.03

Adam Councell

34,608 Ordinary Shares

0.04

42,404

0.04

Joanne Newey

84,080 Ordinary Shares

0.09

91,080

0.08

Capitalised terms used but not defined in this announcement shall have the meaning ascribed to such terms in the Circular unless the context requires otherwise.

Optima Health

Jonathan Thomas, CEO

Heidi Giles, CFO

 

+44(0) 33 0008 5113

media@OptimaHealth.co.uk

Nominated Adviser and Joint Corporate Broker

Panmure Liberum Limited

Emma Earl / Will Goode/ Mark Rogers

Rupert Dearden

Debt Advisory (sole debt adviser on the transaction):

Dan Howlett / Ben Handler

 

 

+44 (0)20 3100 2000

Joint Corporate Broker

Cavendish Capital Markets

Geoff Nash / Ben Jeynes / George Lawson

Julian Morse / Michael Johnson/ Nigel Birks

+ 44 (0)20 7220 0500

 

UK Financial PR Adviser

ICR Healthcare

Mary-Jane Elliott / Angela Gray / Lindsey Neville

optimahealth@icrinc.com

 

About Optima

Optima is the UK's leading provider of occupational health and wellbeing services, directly influencing and improving people's lives for 25 years. Optima's incredible team of professionals quickly and effectively encapsulate client's needs, supporting organisations of all shapes and sizes. Through tailored solutions and innovative systems, Optima offers unparalleled clinical expertise to its clients. These solutions ensure that processes are simple and allow its clients to spend more time focusing on their employees driving a healthy, high-performing workplace. For more information visit www.optima health.co.uk.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

1. Julia Robertson

2. Jonathan Thomas

3. Heidi Giles

4. Simon Arnold

5. Adam Councell

6. Joanne Newey

2

 

Reason for the notification

 

a)

 

Position/status

 

 

1. Non-Executive Chairman

2. Chief Executive Officer

3. Chief Financial Officer

4. Non-Executive Director

5. Non-Executive Director

6. Chief Commercial Officer (PDMR)

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Optima Health plc

b)

 

LEI

 

 

213800TOPWJSRCW4ON08

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of £0.01 each

Identification code

GB00BRSCY602

b)

 

Nature of the transaction

 

 

Purchase of shares

c)

 

Price(s) and volume(s)

Purchase Price

Volume

175 pence per Ordinary Share

1. 4,843

2. 11,500

3. 8,772

4. 11,649

5. 7,796

6. 7,000

d)

 

Aggregated information

- Aggregated volume

51,560 shares

175.00 pence

- Price

e)

 

Date of the transaction

 

 

23 April 2026

f)

 

Place of the transaction

 

 

London Stock Exchange, AIM Market

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSEDESWEMSEDL
Date   Source Headline
16th Jun 20267:00 amRNSFull Year Trading Update
10th Jun 202611:46 amRNSHolding(s) in Company
9th Jun 20269:27 amRNSHolding(s) in Company
29th May 20268:34 amRNSHolding(s) in Company
27th May 202612:40 pmRNSHolding(s) in Company
18th May 202610:51 amRNSHolding(s) in Company
13th May 202612:12 pmRNSHolding(s) in Company
12th May 20265:32 pmRNSHolding(s) in Company
12th May 20261:00 pmRNSHolding(s) in Company
5th May 202610:22 amRNSHolding(s) in Company
5th May 20268:58 amRNSHolding(s) in Company
30th Apr 20263:36 pmRNSHolding(s) in Company
29th Apr 20266:02 pmRNSHolding(s) in Company
28th Apr 202610:39 amRNSHolding(s) in Company
28th Apr 20267:00 amRNSDirector/PDMR Shareholding
27th Apr 20264:27 pmRNSHolding(s) in Company
27th Apr 20267:00 amRNSHolding(s) in Company
23rd Apr 20263:57 pmRNSResult of GM and Underwritten Open Offer
17th Apr 20267:00 amRNSFull Year Trading Update
31st Mar 20267:00 amRNSLaunch of Underwritten Open Offer
30th Mar 20263:20 pmRNSHolding(s) in Company
24th Mar 20264:37 pmRNSIrish FDI Clearance & Expected Acquisition of PAM
23rd Mar 20267:00 amRNSDirectorate Change
12th Mar 20264:04 pmRNSHolding(s) in Company- Replacement
12th Mar 20267:00 amRNSContract Win
12th Mar 20267:00 amRNSContract Win
5th Mar 20263:50 pmRNSHolding(s) in Company
4th Mar 20263:33 pmRNSHolding(s) in Company
24th Feb 20267:00 amRNSDirector/PDMR Shareholding
16th Feb 20267:00 amRNSAppointment of Joint Broker
16th Feb 20267:00 amRNSAcquisition of PAM Healthcare Limited
9th Feb 20269:04 amRNSHolding(s) in Company
2nd Feb 20264:26 pmRNSHolding(s) in Company
10th Dec 20257:00 amRNSInterim Results
13th Nov 20257:00 amRNSNotice of Half Year Results
6th Nov 20252:17 pmRNSHolding(s) in Company
3rd Nov 20255:14 pmRNSHolding(s) in Company
3rd Nov 202511:15 amRNSHolding(s) in Company
3rd Nov 20257:00 amRNSHalf Year Trading Update
31st Oct 20252:00 pmRNSHolding(s) in Company
31st Oct 202511:06 amRNSHolding(s) in Company
20th Oct 20254:35 pmRNSHolding(s) in Company
29th Sep 20252:06 pmRNSHolding(s) in Company
23rd Sep 20257:00 amRNS-ROptima Health launches Optima Health Ireland
1st Sep 20254:06 pmRNSResult of AGM
4th Aug 202510:31 amRNSHolding(s) in Company
1st Aug 20252:55 pmRNSHolding(s) in Company
30th Jul 20257:00 amRNSNotice of AGM and posting of Annual Report
14th Jul 20253:21 pmRNSHolding(s) in Company
9th Jul 20256:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.